JG
IMUX icon

Jefferies Group’s Immunic IMUX Stock Holding History

Jefferies Group’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-28
Closed -$101K – 2271
2016
Q1 		$101K Sell
28
-160
-85% -$556K ﹤0.01% 1970
2015
Q4 		$864K Buy
+188
New +$614K ﹤0.01% 1234
2015
Q2 		– Sell
-8
Closed -$75K – 3393
2015
Q1 		$75K Buy
+8
New +$73.5K ﹤0.01% 1896

Other funds holding IMUX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Jefferies Group's IMUX Position: Q3 2022 in Review

Jefferies Group opened a new position in Immunic (IMUX) in Q3 2022: 3,870 shares worth $122K. The stake represents ﹤0.01% of the portfolio and ranks #1433 among its holdings. This is a return to the name: Jefferies Group previously reported a position in IMUX as recently as Q4 2018.

Jefferies Group first reported a position in IMUX in Q3 2015 and has held it in 7 quarters since. 65 funds tracked by Wall St. Rank hold IMUX as of Q3 2022.

  • Jefferies Group held 3,870 shares of Immunic worth $122K as of Q3 2022.
  • Immunic was a new Jefferies Group position in Q3 2022.
  • Immunic made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1433 holding.
  • Jefferies Group first reported a position in Immunic in Q3 2015 and has held it in 7 quarters since.
  • 65 funds tracked by Wall St. Rank held Immunic as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.